LetterCorrespondence
Commentary on “The Risky Business of Studying Prognosis”
ANNA BRODER and CHAIM PUTTERMAN
The Journal of Rheumatology October 2013, 40 (10) 1771; DOI: https://doi.org/10.3899/jrheum.130393
ANNA BRODER
Division of Rheumatology, Albert Einstein College of Medicine, Forchheimer 701N, 1300 Morris Park Ave., Bronx, New York 10461,
USA.
MD, MScCHAIM PUTTERMAN
Division of Rheumatology, Albert Einstein College of Medicine, Forchheimer 701N, 1300 Morris Park Ave., Bronx, New York 10461,
USA.
MDREFERENCES
- 1.↵
- Lim LS,
- Feldman BM
- 2.↵
- Broder A,
- Putterman C
- 3.↵
- Altman DG
- 4.↵
- Erkan D,
- Derksen WJ,
- Kaplan V,
- Sammaritano L,
- Pierangeli SS,
- Roubey R,
- et al.
- 5.↵
- 6.↵
- Lemeshow S,
- Hosmer DW Jr.
- 7.↵
- 8.↵
In this issue
The Journal of Rheumatology
Vol. 40, Issue 10
1 Oct 2013
Commentary on “The Risky Business of Studying Prognosis”
ANNA BRODER, CHAIM PUTTERMAN
The Journal of Rheumatology Oct 2013, 40 (10) 1771; DOI: 10.3899/jrheum.130393